PMC:7352545 / 64445-64562 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T618","span":{"begin":9,"end":11},"obj":"Body_part"},{"id":"T619","span":{"begin":103,"end":105},"obj":"Body_part"},{"id":"T620","span":{"begin":115,"end":117},"obj":"Body_part"}],"attributes":[{"id":"A618","pred":"fma_id","subj":"T618","obj":"http://purl.org/sig/ont/fma/fma273565"},{"id":"A619","pred":"fma_id","subj":"T619","obj":"http://purl.org/sig/ont/fma/fma273565"},{"id":"A620","pred":"fma_id","subj":"T620","obj":"http://purl.org/sig/ont/fma/fma273565"}],"text":"\n\n6.3.8. DC-SIGN (CD209) is a Binding Candidate for SARS-CoV Entry\nSARS-CoV uses the C-type lectins of DC-SIGN and DC"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T253","span":{"begin":52,"end":60},"obj":"Disease"},{"id":"T254","span":{"begin":67,"end":75},"obj":"Disease"}],"attributes":[{"id":"A253","pred":"mondo_id","subj":"T253","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A254","pred":"mondo_id","subj":"T254","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"\n\n6.3.8. DC-SIGN (CD209) is a Binding Candidate for SARS-CoV Entry\nSARS-CoV uses the C-type lectins of DC-SIGN and DC"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T923","span":{"begin":9,"end":11},"obj":"http://purl.obolibrary.org/obo/CL_0000451"},{"id":"T924","span":{"begin":28,"end":29},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T925","span":{"begin":103,"end":105},"obj":"http://purl.obolibrary.org/obo/CL_0000451"},{"id":"T926","span":{"begin":115,"end":117},"obj":"http://purl.obolibrary.org/obo/CL_0000451"}],"text":"\n\n6.3.8. DC-SIGN (CD209) is a Binding Candidate for SARS-CoV Entry\nSARS-CoV uses the C-type lectins of DC-SIGN and DC"}

{"project":"LitCovid-sentences","denotations":[{"id":"T620","span":{"begin":2,"end":8},"obj":"Sentence"},{"id":"T621","span":{"begin":9,"end":66},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"\n\n6.3.8. DC-SIGN (CD209) is a Binding Candidate for SARS-CoV Entry\nSARS-CoV uses the C-type lectins of DC-SIGN and DC"}